Based on editorial board decision, Iranian Endodontic Journal does not accept advertising for products or services. All publications which have the capacity of an advertising and/or commercially sponsored articles are independent from editorial decisions. IEJ does not endorse any product or service marked as an advertisement or promoted by a sponsor in its publications. Editorial content is not compromised by commercial or financial interests, or by any specific arrangements with advertising clients or sponsors.
Articles appearing in IEJ are “open access”. The published articles are universally and freely accessible via the Internet, from the related website and in at least one widely and internationally recognized open access repository (such as PubMed Central).
Permanency of articles
IEJ deposits the articles that it publishes in a prestigious digital archive (PubMed Central) to guarantee long-term digital preservation.
Article corrections and retractions
Corrections to or retractions of published articles will be made by publishing an erratum or retraction note and without altering the original article. Thus the original article remains in the public domain and the erratum or retraction will be widely indexed.
Standards and affiliations
Editorial team of IEJ are committed to maintaining high standards through full and inflexible double-blind peer review.
The Editor of IEJ endorse the policies of the International Committee of Medical Journal Editors, including those that cover overlapping publications.
Iranian Endodontic Journal is a member of COPE (Committee on Publication Ethics) since 2016. It is concerned with the integrity of peer-reviewed publications in science, particularly biomedicine.
Creative Commons (CC) is a non-profit organization that promotes the creative re-use of intellectual works, whether they are owned or public-domain. Creative Commons Attribution License (CC-BY) allows articles, which are made freely available, to be shared and re-used without restriction, provided that appropriate credit is given to the original author(s) and the source.
Peer Review Policy
We ask authors and peer-reviewers to submit their articles and reports via our secure online system (http://journals.sbmu.ac.ir/iej/login).
Editorial decisions are not a matter of counting votes or numerical rank assessments, and we do not always follow the majority recommendation. We try to evaluate the strength of the arguments raised by each reviewer and by the authors, and we may also consider other information not available to either party. Our primary responsibilities are to our readers and to the scientific community at large, and in deciding how best to serve them, we must weigh the claims of each paper against the many others also under consideration.
Reviewers are welcome to recommend a particular course of action, but they should bear in mind that the other reviewers of a particular paper may have different technical expertise and/or views, and the editors may have to make a decision based on conflicting advice. The most useful reports, therefore, provide the editor with the information on which a decision should be based. Setting out the arguments for and against publication is often more helpful to the editor than a direct recommendation one way or the other.
Scientific and Initial Screening
The staff of IEJ would check the structure and content of manuscripts to ensure compliance with standard structures (based on the type of study), the aim and scope of the IEJ, standard guidelines and adherence to ethical issues. In this step, articles would be screened in the shortest possible time. As a result, such triage would help the editor in making fair final decisions on articles and eventually improve the ultimate quality of published articles.
Double blind peer review process
Double-blind peer review is a model of peer review which reduces biases by allowing reviewer(s) to judge the manuscript only based on scientific content, un-biased by information of who the author(s) is/are.
Submitted manuscripts are primarily allocated with a submission code and all the future contacts should be based on the code. Manuscripts submitted to IEJ which do not adhere to the “Instructions for Authors” will be returned for appropriate revision to be in line with the instructions for authors. They may then be resubmitted. Through a double-blind review, the articles will be reviewed by at least Three external peer reviewers and our statisticians who check the articles for any methodological flaws, format, and their compliance with the instructions of IEJ. Neither the peer reviewers nor the authors are revealed to each other. The existence of a submitted manuscript is not revealed to anyone other than the reviewers and editorial staff. Reviewers are required to keep manuscripts and their information confidential. They must not use knowledge of the manuscript before its publication for their personal interests. Reviewers should declare their conflicts of interest and decline review if a conflict exists. Knowing the author(s) must not affect their comments and decision. Their comments should be constructive, honest, and polite. The reviewers’ comments will be passed to the authors and their responses to the comments along with the reviewers’ comments will then be evaluated by a final reviewer who can be a member of the Editorial Board and the Editor-in-Chief. The Editor, on the basis of the comments, and the standards of IEJ, will decide which articles should be rejected or published.
It should be noted that articles submitted by the staff and editors of the IEJ will also be subjected to peer review and the authors will be completely blind to the evaluation process of their article until a final decision has been made.
Editorial Independence and responsibilities
Although the IEJ is sponsored financially by Iranian Center for Endodontic Research (ICER), it benefits from editorial freedom. The editor evaluate and accept articles based only on significance, originality, validity, and adherence to the aims and scope of the IEJ.
Our editorial policy is consistent with the principles of editorial independence presented by the World Association of Medical Editors (WAME: http://www.wame.org/).
The Editor has complete responsibility and authority to reject/accept an article. Editor should has no conflict of interest with respect to articles he/she reject/accept. When errors are found in a manuscript, the editor promotes publication of corrections or retractions. The anonymity of reviewers is preserved.
Editing referees' reports
As a matter of policy, we do not suppress reviewers' reports; any comments that were intended for the authors are transmitted, regardless of what we may think of the content. On rare occasions, we may edit a report to remove offensive language or comments that reveal confidential information about other matters. We ask reviewers to avoid statements that may cause needless offence; conversely, we strongly encourage reviewers to state plainly their opinion of a paper.
IEJ is committed to rapid editorial decisions and publication, and we believe that an efficient editorial process is a valuable service both to our authors and to the scientific community as a whole. We therefore ask reviewers to respond as soon as possible. If reviewers anticipate an unreasonable delay, we ask them to let us know so that we can keep the authors informed and, where necessary, find alternatives.
The IEJ is a member of the Committee on Publication Ethics (COPE). COPE’s flowcharts and guidelines are approached in confronting any ethical misbehavior. The Journal also follows the guidelines mentioned in the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals issued by the International Committee of Medical Journal Editors (ICMJE).
Authorship and Author’s Responsibility
According to the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals, released by the ICMJE, an “Author” is generally considered to be someone who concurrently meets the following conditions 1, 2, 3, and 4.
1-Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
2-Drafting the work or revising it critically for important intellectual content; AND
3-Final approval of the version to be published; AND
4-Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
The corresponding author takes primary responsibility for communication with the journal during the manuscript submission, peer review, and publication process, and typically ensures that all the journal’s administrative requirements, such as providing details of authorship, ethics committee approval, clinical trial registration documentation, and gathering conflict of interest statements, are properly completed. The corresponding author should respond to editorial queries throughout the submission and peer review process in a timely manner, and should cooperate with any requests from the journal after publication.
IEJ does not allow adding authors or changing the first or the corresponding authors after the final acceptance of the article. If any author wishes to be removed from the byline, he or she should submit a letter signed by the author, as well as all other authors, indicating his or her wish to be deleted from the list of authors. Any change in the name order in the byline requires a letter signed by all authors indicting agreement with the same.
Submission of an article implies that the work described has not been published previously, that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out.
Declaration of Interest
Authors are required to disclose all relationships or interests in relation to their work. All submitted manuscripts must include a “Conflict of Interest” section at the end of the manuscript listing all financial and non-financial conflict of interests. A competing interest exists when the authors’ interpretation of data or presentation of information may be influenced by their personal/financial relationship with other people/organizations.
Authors should disclose any financial competing interests but also any non-financial competing interests that may cause them embarrassment if they were to become public after the publication of the article. Financial competing interests include (but are not limited to):
- Research grants from funding agencies
- Financial support for educational programs
- Employment or consultation
- Position on advisory board or board of directors or other type of management relationships
-Financial relationships, for example receiving reimbursements, fees, funding, or salary from an organization that may in any way gain or lose financially from the publication of the article, either now or in the future
- Intellectual property rights (e.g. patents, copyrights and royalties from such rights)
- Holdings of spouse and/or children that may have financial interest in the work
In addition, non-financial interests that may be important to readers should be disclosed. These may include but are not limited to political, personal, religious, ideological, academic, and intellectual competing interests.
Editor-in-chief may ask for further information relating to competing interests. Editors and reviewers are also required to declare any competing interests and will be excluded from the peer review process if a competing interest exists.
Role of the funding source
The authors request to identify who provided financial support for the conduct of the research and to briefly describe the role of the sponsor(s), if any, in the “methods and materials” section.
Human and Animal Rights
Studies that involve human beings must adhere to the principles of the “Declaration of Helsinki” (The Code of Ethics of the World Medical Association) The trials must registered in ethical committee of the research center or University where the study was carried out; the “Methods and Materials” section should include a statement that the study approved by an appropriate ethics committee too.
Randomized clinical trials should be registered in appropriate trial registries [i.e. Clinical Trials.gov or Iranian Registry of Clinical Trials website (www.irct.ir)] approved by the WHO and their registration number should be mentioned in the title page.
Where human subjects are used, the informed consent explaining the nature of the procedure and possible discomforts and risks should be obtained from all patients who participated in the experimental investigation and subjects should be able to freely reject participation.
If animals are used, a statement protocol approval by the institutional animal care and use committee must be included. All animal experiments should comply with the ARRIVE guidelines.
Manuscripts may be rejected if the Editor considers that the research has not been carried out within an appropriate ethical framework. In rare cases, Editor may contact the ethics committee for further information.
All patients and volunteers in a research project should be carefully informed about the aims of the trial and any possible side effects of the drugs and interventions. Written informed consent from the participants or their legal guardians is compulsory for any such studies. The IEJ reserves the right to request the related documents. Articles that require informed consent should cover related statements in the “Methods and Materials” section.
Originality and Duplicate Publication
Manuscripts under review or published by other journals will not be accepted for publication in IEJ, and articles published in this journal are not allowed to be reproduced in whole in any type of publication without permission of the IEJ. Figures and tables can be used freely if original source is verified according to Creative Commons Non-Commercial License. It is mandatory for all authors to resolve any copyright issues when citing a figure or table from a different journal that is not open access.
Process to Manage Research and Publication Misconduct
The IEJ will continuously work towards observing publication misconduct such as plagiarism, redundant (duplicate) publication, falsification, fraudulent or fabricated data, changes in authorship, undisclosed conflict of interest, ethical problem with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and etc. When the IEJ faces suspected cases of research and publication misconduct, the resolving process will be followed by guidelines provided by the "Committee on Publication Ethics (COPE)". The complete guidelines appear on COPE website: https://publicationethics.org/
The IEJ uses the COPE flowchart for retraction of a published article to determine whether a published article should be retracted.
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of IEJ and will not be made available for any other purpose or to any other party.